REBECCA WALDING: Open Payments
NPI 1215125216 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 10 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $209 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $159 |
| Insulet Corporation | 1 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: EVENITY, KRYSTEXXA, OMNIPOD, COBENFY, INGREZZA, ARISTADA, VRAYLAR, REXULTI.
Industry payments across IA — which companies pay providers there.
